An Effective Strategy for Communities Facing Methamphetamine
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
TREATED with CRUELTY: ABUSES in the NAME of DRUG REHABILITATION Remedies
TREATED WITH CRUELTY ABUSES IN THE NAME OF DRUG REHABILITATION Copyright © 2011 by the Open Society Foundations All rights reserved, including the right to reproduce this book or portions thereof in any form. For more information, contact: International Harm Reduction Development Program Open Society Foundations www.soros.org/harm-reduction Telephone: 1 212 548 0600 Fax: 1 212 548 4617 Email: [email protected] Cover photo: A heroin user stands in the doorway at the Los Tesoros Escondidos Drug Rehabilita- tion Center in Tijuana, Mexico. Addiction treatment facilities can be brutal and deadly places in Mexico, where better, evidence-based alternatives are rarely available or affordable. (Sandy Huf- faker/ Getty Images) Editing by Roxanne Saucier, Daniel Wolfe, Kathleen Kingsbury, and Paul Silva Design and Layout by: Andiron Studio Open Society Public Health Program The Open Society Public Health Program aims to build societies committed to inclusion, human rights, and justice, in which health-related laws, policies, and practices reflect these values and are based on evidence. The program works to advance the health and human rights of marginalized people by building the capacity of civil society leaders and organiza- tions, and by advocating for greater accountability and transparency in health policy and practice. International Harm Reduction Development Program The International Harm Reduction Development Program (IHRD), part of the Open Society Public Health Program, works to advance the health and human rights of people who use drugs. Through grantmaking, capacity building, and advocacy, IHRD works to reduce HIV, fatal overdose and other drug-related harms; to decrease abuse by police and in places of detention; and to improve the quality of health services. -
Supporting the Drug Court Process: What You Need to Know For
U.S. Department of Justice Office of Justice Programs Bureau of Justice Assistance Supporting the Drug Court Process:What You Need To Know for Effective Decisionmaking MONOGRAPHand Program Evaluation F EBRUARY 2003 SEARCH, The National Consortium for Justice Information and Statistics U.S. Department of Justice Office of Justice Programs 810 Seventh Street NW. Washington, DC 20531 John Ashcroft Attorney General Deborah J. Daniels Assistant Attorney General Richard R. Nedelkoff Director, Bureau of Justice Assistance Office of Justice Programs Home Page www.ojp.usdoj.gov Bureau of Justice Assistance Home Page www.ojp.usdoj.gov/BJA NCJ 197259 This document was prepared by SEARCH,The National Consortium for Justice Information and Statistics, under the Drug Court Training and Technical Assistance Program, under grant number 98–MU–VX–K017, awarded by the Office of Justice Programs, U.S. Department of Justice. The opinions, findings, and conclusions or recommendations expressed in this document are those of the authors and do not necessarily represent the official position or policies of the U.S. Department of Justice. The Bureau of Justice Assistance is a component of the Office of Justice Programs, which also includes the Bureau of Justice Statistics, the National Institute of Justice, the Office of Juvenile Justice and Delinquency Prevention, and the Office for Victims of Crime. Notice n November 2002, the Bureau of Justice Assistance I Bureau of Justice 810 Seventh Street NW. Assistance (BJA) Washington, DC 20531 assumed responsibility Telephone: (202) 616–5001 for administering the Drug Court Grant Fax: (202) 514–6452 Program and the Drug Court Training and E-mail: [email protected] Technical Assistance Program. -
2008 Idaho Felony Drug Court Outcome Evaluation Report
An Examination of Idaho’s Felony Drug Courts: Findings and Recommendations FINAL REPORT Shelley Johnson Listwan, Ph.D. Institute for the Study and Prevention of Violence Department of Justice Studies Kent State University James Borowiak, M.A. Department of Justice Studies Kent State University & Edward J. Latessa, Ph.D. Center for Criminal Justice Research Division of Criminal Justice University of Cincinnati August 2008 ______________________________________________ This report was supported through a grant from the Idaho Supreme Court & the Substance Abuse and Mental Health Services Administration (CFDA 93.243). Views expressed are those of the authors and do not necessarily reflect the views of either funding agency. Table of Contents Acknowledgements………………………………………………………………………………3 List of Exhibits…………………………………………………………………………………...4 Section I. Overview………………...………………………………………………………10 Section II. Organizational Issues & Needs ………………………………………………..14 Methodology…………………………………………………………………….14 Sample…………………………………………………………………………...14 Court Descriptions……………………………………………………………...16 Results…………………………………………………………………………...23 Summary………………………………………………………………………...39 Section III. Statewide Outcome Evaluation Results……………………………………….41 Methodology…………………………………………………………………….41 Sample…………………………………………………………………………...41 Measures………………………………………………………………………...45 Analysis………………………………………………………………………….47 Results…………………………………………………………………………...47 Summary………………………………………………………………………..74 Section IV. GRPA Data Summary………………………………………………………….77 Methodology…………………………………………………………………….78 -
Western Judicial Circuit Felony Drug Court
Western Judicial Circuit Felony Drug Court (Athens-Clarke and Oconee Counties) PARTICIPANT HANDBOOK This handbook belongs to: 325 E. Washington Street, Suite 210 Athens, Georgia 30601 (706) 208-7078 (706) 613-3179 (fax) Table of Contents Welcome 3 Overview 4-5 Confidentiality 5 Treatment 5 Program Phases 6-10 Commencement 11 Program Rules 12-14 Program Fees 15 The Drug Court Team 15 Staffings 15 Court Appearances 16 Incentives 17 Sanctions and Treatment Responses 17 Termination 18 Drug/Chemical Testing 19 Prohibited Drugs/Permitted Medications 20-27 Travel/Leave Requests 27 Compliance & Home Visits/Job Checks, Searches 28 Search Requirements 28 Commencement Ceremony 29 Conclusion 29 Important Phone Numbers 30 Community Resources 31 Attachment I: Random Drug Screen Policy Attachment II: Urine Abstinence Testing/Incidental Alcohol Exposure Contract (original signed copy on file with Felony Drug Court) Attachment III: Emergency On-call Telephone Policy Attachment IV: Felony Drug Court Contract 2 Welcome to the Western Judicial Circuit Felony Drug Court! This Handbook was designed to answer your questions and provide specific information about what you must do in order to successfully complete the requirements of the Western Judicial Circuit Felony Drug Court Program. As a participant, you are expected to follow the instructions found in this Handbook, as well as the instructions of the Felony Drug Court Judge, Staff, and Treatment Provider. You will also be expected to comply with the treatment plan developed for you by your Treatment Provider. This handbook is not exhaustive and there is no possible way to make it complete and detailed to answer every question or situation that arises. -
Retrospective Evaluation of Drug Courts in Clark County (Las Vegas) and Multnomah County (Portland)
The author(s) shown below used Federal funds provided by the U.S. Department of Justice and prepared the following final report: Document Title: From Whether to How Drug Courts Work: Retrospective Evaluation of Drug Courts in Clark County (Las Vegas) and Multnomah County (Portland) Author(s): John S. Goldkamp ; Michael D. White ; Jennifer B. Robinson Document No.: 194124 Date Received: 05/05/2002 Award Number: 98-DC-VX-K001 This report has not been published by the U.S. Department of Justice. To provide better customer service, NCJRS has made this Federally- funded grant final report available electronically in addition to traditional paper copies. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. R CRIME AND JUSTICE RESEARCHINSTITUTE .---- PROPERTY OF National Criminal Justice Reference Service (NCJRS) Box 6000 Rockville, MD 20849-6000 From Whether to How Drug Courts Work: Retrospective Evaluation of Drug Courts in , Clark County (Las Vegas) and Multnomah County (Portland) Phase II Report,fiorn the National Evaluation of Drug Courts (I) Johi S. Goldkamp Temple University Michael D. White University of North Florida Jennifer B. Robinson University of Ottawa c Approved By: Bate: The researc scribed in this report was supported by grant #98-DC-VX-K001 from the National Institute of Justice, United States Department of Justice. The points of view expressed in the document do not represent the official positions of the National Institute of Justice, the local justice agencies in Multnomah County and Clark County, nor the Federal Government. -
DRUG COURT REVIEW Winter 2019
DRUG COURT REVIEW Winter 2019 Rural Treatment Court Programs EDITOR IN CHIEF Julie Marie Baldwin, American University ASSOCIATE EDITORS Leola A. Abraham, American University John M. Eassey, American University EDITORIAL SUPPORT Steve Collins, American University Zephi Francis, American University Preeti P. Menon, American University ADVISORY COMMITTEE Jon D. Berg, Substance Abuse and Mental Health Services Administration Jerry Gardner, Tribal Law and Policy Institute Peggy Fulton Hora, Justice Speakers Institute Preeti Menon, American University Carrie F. Mulford, National Institute on Drug Abuse Roger H. Peters, University of South Florida Noreen Plumage, South Dakota State Court Administrators Office Annie Schachar, Center for Court Innovation Faye S. Taxman, George Mason University Gregory D. Torain, US Department of Justice EDITORIAL OFFICE Justice Programs Office American University 4801 Massachusetts Ave NW, Suite 508 Washington, DC 20016 This publication was supported by Grant No. 2016-DC-BX-K008 awarded by the Bureau of Justice Assistance. The Bureau of Justice Assistance is a component of the Department of Justice’s Office of Justice Programs, which also includes the Bureau of Justice Statistics, the National Institute of Justice, the Office of Juvenile Justice and Delinquency Prevention, the Office of Victims of Crime, and the SMART Office. Points of view or opinions in this document are those of the authors and do not necessarily represent the official position or policies of the US Department of Justice. Drug Court Review Winter 2019 3 Introduction to the Issue on Rural 4 - 7 Treatment Court Programs John M. Eassey The Effect of Disproportionate 8 - 25 Sanctioning on Client Noncompliance Jamie C. Vaske Treatment Needs and Gender 26 - 49 Differences Among Clients Entering a Rural Drug Treatment Court with a Co-occurring Disorder Paige M. -
Pennsylvania Drug and Alcohol Abuse Control Act."
§ 1690.101. Short title This act shall be known and may be cited as the "Pennsylvania Drug and Alcohol Abuse Control Act." § 1690.102. Definitions (a) The definitions contained and used in the Controlled Substance, Drug, Device and Cosmetic Act shall also apply for the purposes of this act. (b) As used in this act: "CONTROLLED SUBSTANCE" means a drug, substance, or immediate precursor in Schedules I through V of the Controlled Substance, Drug, Device and Cosmetic Act. "COUNCIL" means the Pennsylvania Advisory Council on Drug and Alcohol Abuse established by this act. "COURT" means all courts of the Commonwealth of Pennsylvania, including magistrates and justices of the peace. "DEPARTMENT." The Department of Health. "DRUG" means (i) substances recognized in the official United States Pharmacopeia, or official National Formulary, or any supplement to either of them; and (ii) substances intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in man or other animals; and (iii) substances (other than food) intended to affect the structure or any function of the body of man or other animals; and (iv) substances intended for use as a component of any article specified in clause (i), (ii) or (iii), but not including devices or their components, parts or accessories. "DRUG ABUSER" means any person who uses any controlled substance under circumstances that constitute a violation of the law. "DRUG DEPENDENT PERSON" means a person who is using a drug, controlled substance or alcohol, and who is in a state of psychic or physical dependence, or both, arising from administration of that drug, controlled substance or alcohol on a continuing basis. -
Drug Court Practitioner
Drug Court Practitioner February 2016 Fact SheetVol. XI, No. 1 Understanding and Detecting Prescription Drug Misuse and Misuse Disorders By Sandra Lapham, MD, MPH, DFASAM Senior Research Scientist, Behavioral Health Research Center of the Southwest, Pacific Institute for Research and Evaluation his fact sheet is designed for court professionals. It describes prescription T drug misuse and provides information on: • The attributes of the most commonly misused and addictive prescription drugs • The extent and consequences of misuse • Side effects and toxicity • Characteristics of those who are most likely to misuse prescription drugs • Signs and symptoms of misuse • Ways to identify and treat those who may have developed a drug use disorder, including a section on medication-assisted treatment of opioid use disorder • Educational and technical assistance resources on this topic from SAMHSA and other organizations Prescription Drug Misuse drug causes (SAMHSA, 2012). This definition and the Most Commonly covers a wide range of behaviors, from using someone else’s medication to address a Misused Drugs legitimate medical need to misusing prescription The Substance Abuse and Mental Health medications to stay awake, get to sleep, calm Services Administration (SAMHSA) defines down, enhance job or athletic performance, or nonmedical prescription drug misuse as the change one’s mood. use of prescription pain relievers, tranquilizers, People who misuse prescription medications stimulants, sedatives, and other prescription may not understand that, although drugs for drugs in a way other than prescribed, such as treating pain and other medical conditions are for perceived medical need or for the feeling the generally safe when taken as prescribed, they Table 1. -
Resource Guide for Drug Court Applicants
U.S. Department of Justice Office of Justice Programs Bureau of Justice Assistance Drug Court Discretionary Grant Program: FY 2010 Enhancing Adult Drug Court Services, Coordination, and Treatment Solicitation Requirements Resource Guide Table of Contents Introduction ............................................................................................................................................................... 1 About the Requirements Resource Guide .......................................................................................................... 1 Assistance with the Proposal .............................................................................................................................. 1 The Drug Court Movement ................................................................................................................................. 1 Partnership with Treatment ................................................................................................................................. 2 Key Components of Drug Courts........................................................................................................................ 2 General Information................................................................................................................................................... 4 Definitions........................................................................................................................................................... 4 Program Provisions ........................................................................................................................................... -
Recent Changes in Drug Abuse Scenario the Novel Psychoactive Substances (NPS) Phenomenon
brain sciences Recent Changes in Drug Abuse Scenario The Novel Psychoactive Substances (NPS) Phenomenon Edited by Fabrizio Schifano Printed Edition of the Special Issue Published in Brain Sciences www.mdpi.com/journal/brainsci Recent Changes in Drug Abuse Scenario Recent Changes in Drug Abuse Scenario The Novel Psychoactive Substances (NPS) Phenomenon Special Issue Editor Fabrizio Schifano MDPI • Basel • Beijing • Wuhan • Barcelona • Belgrade Special Issue Editor Fabrizio Schifano University of Hertfordshire UK Editorial Office MDPI St. Alban-Anlage 66 4052 Basel, Switzerland This is a reprint of articles from the Special Issue published online in the open access journal Brain Sciences (ISSN 2076-3425) in 2018 (available at: https://www.mdpi.com/journal/brainsci/ special issues/drug abuse scenario) For citation purposes, cite each article independently as indicated on the article page online and as indicated below: LastName, A.A.; LastName, B.B.; LastName, C.C. Article Title. Journal Name Year, Article Number, Page Range. ISBN 978-3-03897-507-6 (Pbk) ISBN 978-3-03897-508-3 (PDF) c 2019 by the authors. Articles in this book are Open Access and distributed under the Creative Commons Attribution (CC BY) license, which allows users to download, copy and build upon published articles, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. The book as a whole is distributed by MDPI under the terms and conditions of the Creative Commons license CC BY-NC-ND. Contents About the Special Issue Editor ...................................... vii Fabrizio Schifano Recent Changes in Drug Abuse Scenarios: The New/Novel Psychoactive Substances (NPS) Phenomenon Reprinted from: Brain Sci. -
Licit and Illicit Drug Use During Pregnancy: Maternal, Neonatal and Early Childhood Consequences
SUBSTANCE ABUSE IN CANADA 2013 Licit and Illicit Drug Use during Pregnancy: Maternal, Neonatal and Early Childhood Consequences By Loretta Finnegan With A Call to Action by Franco Vaccarino and Colleen Dell This document was published by the Canadian Centre on Substance Abuse (CCSA). CCSA activities and products are made possible through a financial contribution from Health Canada. The views of CCSA do not necessarily represent the views of the Government of Canada. The subjects in the photographs used throughout this publication are models who have no relation to the content. The vignettes are fictional and do not depict any actual person. Suggested citation: Finnegan, L. (2013). Substance abuse in Canada: Licit and illicit drug use during pregnancy: Maternal, neonatal and early childhood consequences. Ottawa, ON: Canadian Centre on Substance Abuse. © Canadian Centre on Substance Abuse 2013. CCSA, 75 Albert St., Suite 500 Ottawa, ON K1P 5E7 Tel.: 613-235-4048 Email: [email protected] This document can also be downloaded as a PDF at www.ccsa.ca. Ce document est également disponible en français sous le titre : Toxicomanie au Canada 2013 : Consommation de drogues licites et illicites pendant la grossesse : Répercussions sur la santé maternelle, néonatale et infantile ISBN 978-1-77178-041-4 Licit and Illicit Drug Use during Pregnancy: Maternal, Neonatal and Early Childhood Consequences Prepared for the Canadian Centre on Substance Abuse Loretta P. Finnegan, M.D., LLD, (Hon.), ScD (Hon.); President, Finnegan Consulting, LLC; Professor of Pediatrics, Psychiatry and Human Behavior, Thomas Jefferson University (Retired); Founder and Former Director of Family Center, Comprehensive Services for Pregnant Drug Dependent Women, Philadelphia, PA; Former Medical Advisor to the Director, Office of Research on Women’s Health, National Institutes of Health, U.S. -
A Theory of Civil Problem-Solving Courts
GW Law Faculty Publications & Other Works Faculty Scholarship 2018 A Theory of Civil Problem-Solving Courts Jessica K. Steinberg George Washington University Law School, [email protected] Follow this and additional works at: https://scholarship.law.gwu.edu/faculty_publications Part of the Law Commons Recommended Citation Steinberg, Jessica, A Theory of Civil Problem-Solving Courts (2). 93 N.Y.U. L. Rev. (forthcoming 2018); GWU Law School Public Law Research Paper No. 2018-32; GWU Legal Studies Research Paper No. 2018-32. Available at SSRN: https://ssrn.com/abstract=3219306 This Article is brought to you for free and open access by the Faculty Scholarship at Scholarly Commons. It has been accepted for inclusion in GW Law Faculty Publications & Other Works by an authorized administrator of Scholarly Commons. For more information, please contact [email protected]. Forthcoming, 93 NYU L. Rev. __ (2018) A THEORY OF CIVIL PROBLEM-SOLVING COURTS JESSICA K. STEINBERG* This Article is the first to develop a problem-solving theory for the civil justice system. Drug courts pioneered the problem-solving model in the 1990s to pursue therapeutic goals as an alternative to “assembly line” jail- based sentencing. This Article explores the potential for migration of the drug court framework into the two most commonly adjudicated private law cases: rental housing and consumer debt. Three structural conditions in the civil courts—systemic lack of counsel, high-volume dockets, and corporate capture of the small claims process—routinely position vulnerable classes of individuals on the losing end of litigation. In the aggregate, these conditions have rendered the civil justice system predictably ineffective in combatting recurring social issues such as substandard housing and unscrupulous debt collection.